Retaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent

Author： Hanson Britt Erika Vesole David H

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.18, Iss.9, 2009-09, pp. : 1375-1383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Farnesyltransferase Inhibitor as Anticancer Agent

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 6, 2009-01 ,pp. : 638-652

Bentham Science Publishers

Access to resources Recommend Favorite

Disposition of Vorinostat, A Novel Histone Deacetylase Inhibitor and Anticancer Agent, in Preclinical Species

Drug Metabolism Letters, Vol. 1, Iss. 2, 2007-04 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite

Remacemide Hydrochloride: A Novel Antiepileptic Agent

By Davies J.A.

General Pharmacology, Vol. 28, Iss. 4, 1997-04 ,pp. : 499-502

Elsevier

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics – an update

By Neckers Len Neckers Katharine

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 137-149

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents

By Neckers Len Neckers Katharine

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 277-288

Informa Healthcare

Access to resources Recommend Favorite